MORGAN ADELMAN: Open Payments
NPI 1760009849 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 23 payments from 14 companies in 2025. Trend: 2023 $676 · 2024 $530 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $84 |
| Dexcom, Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| ABBVIE INC. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Eisai Inc. | 1 | $23 |
| Renalytix AI, Inc. | 1 | $21 |
| Globus Medical, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
Products named: Dexcom G6 Transmitter, TRELEGY ELLIPTA, Rybelsus, JARDIANCE, Ozempic, GEMTESA, Leqembi, LINZESS.
Industry payments across AZ — which companies pay providers there.
